PRDM1 and hepatocellular carcinoma: Among the 16 TFs, several have previously been linked to HCC and immune activities, including PRDM1 in CD8+ T cells (60), SPI1 in myeloid cell development, FOXP3 in regulatory T cells (61), and TCF7 in HCC (62).